Citadel Advisors’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,310
| Closed | -$55.5K | – | 6566 |
|
|
2023
Q4 | $55.5K | Buy |
+4,310
| New | +$55.5K | ﹤0.01% | 5078 |
|
|
2023
Q2 | – | Sell |
-2,128
| Closed | -$30.6K | – | 6202 |
|
|
2023
Q1 | $30.6K | Buy |
2,128
+1,026
| +93% | +$14.8K | ﹤0.01% | 5301 |
|
|
2022
Q4 | $17.5K | Buy |
1,102
+193
| +21% | +$3.07K | ﹤0.01% | 5579 |
|
|
2022
Q3 | $14K | Buy |
+909
| New | +$14K | ﹤0.01% | 5589 |
|
|
2021
Q3 | – | Sell |
-2,537
| Closed | -$140K | – | 6816 |
|
|
2021
Q2 | $140K | Buy |
2,537
+1,614
| +175% | +$89.1K | ﹤0.01% | 5785 |
|
|
2021
Q1 | $56K | Buy |
+923
| New | +$56K | ﹤0.01% | 6070 |
|
|
2020
Q2 | – | Sell |
-400
| Closed | -$22K | – | 5049 |
|
|
2020
Q1 | $22K | Buy |
400
+166
| +71% | +$9.13K | ﹤0.01% | 4649 |
|
|
2019
Q4 | $19K | Buy |
+234
| New | +$19K | ﹤0.01% | 4512 |
|
|
2019
Q1 | – | Sell |
-238
| Closed | -$22K | – | 4837 |
|
|
2018
Q4 | $22K | Buy |
238
+115
| +93% | +$10.6K | ﹤0.01% | 4240 |
|
|
2018
Q3 | $18K | Buy |
+123
| New | +$18K | ﹤0.01% | 4148 |
|
|
2017
Q2 | – | Sell |
-192
| Closed | -$20K | – | 3965 |
|
|
2017
Q1 | $20K | Buy |
+192
| New | +$20K | ﹤0.01% | 3517 |
|